Baxter International

Baxter International (BAX) Q4 Earnings and Revenues Surpass Estimates

Baxter International (BAX) came out with quarterly earnings of $0.78 per share, beating the Zacks Consensus Estimate of $0.73 per share. This compares to earnings of $0.64 per share a year ago. These figures are adjusted for non-recurring items.

This quarterly report represents an earnings surprise of 6.85%. A quarter ago, it was expected that this drug and medical device maker would post earnings of $0.74 per share when it actually produced earnings of $0.80, delivering a surprise of 8.11%.

...

https://finance.yahoo.com/news/baxter-in...01520.html

Baxter (BAX) Beats on Q1 Earnings and Revenue Estimates

...

Earnings: Baxter’s adjusted earnings of 76 cents per share beat the Zacks Consensus Estimate of 68 cents and increased from 70 cents from the year-ago quarter.

Revenues: Baxter posted worldwide sales of $2.63 billion, beating the Zacks Consensus Estimate for revenues of $2.62 billion. At constant currency (cc), revenues increased almost 2% on a year-over-year basis.

...

https://finance.yahoo.com/news/baxter-ba...12350.html

Baxter (BAX) Misses Q3 Revenue Estimates, Issues Guidance

Baxter International Inc. BAX reported preliminary third-quarter 2019 revenues of $2.85 billion, which missed the Zacks Consensus Estimate of $2.86 billion by 0.5%. However, the top line rose 3% year over year on a reported basis and 5% on both constant currency and operational basis.

However, the company hasn’t released any earnings number in its preliminary results.

Geographical Details

Baxter reports preliminary operating results through three geographic segments — Americas (North and South America), EMEA (Europe, Middle East and Africa) and APAC (Asia Pacific).

In Americas, Baxter recorded revenues of $1.53 billion, up 2.5% on a year-over-year basis.

In EMEA, revenues totaled $730 million, up 3.3% from the year-ago quarter.

...

https://finance.yahoo.com/news/baxter-ba...02988.html



In APAC, revenues of $587 million increased 4.3% from the prior-year quarter.